ABB supplying electrical system for the first floating LNG terminal in Singapore.


ABB has been commissioned by Hanwha Ocean to supply a complete electric power and propulsion system for Singapore's first floating liquefied natural gas (LNG) terminal. With this contract, ABB is further strengthening its collaboration with Hanwha Ocean.

ABB is supplying the complete electric power and propulsion system for Singapore’s first floating LNG terminal. According to a press release, the company has been commissioned by the South Korean shipbuilding company Hanwha Ocean, which is based in the city of Geoje and will handle construction of the terminal. The Floating Storage and Regasification Unit (FSRU) is expected to be delivered to the Japanese owner Mitsui O.S.K. Lines (MOL) in 2027, before being contracted for charter by Singapore LNG Corporation Pte Ltd on a long-term basis.

ABB's integrated electrical system on the FSRU includes a medium voltage generator, 6.6 kilovolt switchboards for cargo and regasification, as well as the motor, transformer and drive for propulsion. In terms of condition monitoring, the terminal will also be equipped with ABB’s remote control and remote diagnostics system, as well as an enhanced power protection system.

Upon completion, the FSRU will be moored at Jurong Port and connected to the gas network in 2030 under the management of MOL. It will have a capacity of 200,000 cubic meters of LNG and is seen as a strategic investment in Singapore’s energy infrastructure.

“We are proud to continue our long-lasting collaboration with Hanwha Ocean by supplying an integrated electrical system for Singapore’s first FSRU”, comments Rune Braastad, Senior Vice President, Global Business Line Manager Marine Systems at ABB, adding that: “This collaboration underscores our shared commitment to innovation, reliability, and sustainability, and is ABB’s latest contribution to the critical infrastructure supporting Singapore’s position as an important LNG hub in Asia”.


Source: swisstrade
https://swisstrade.com/news

Next
Next

US tariff exemptions lessen impact on pharmaceutical industry.